NTRK fusion in Japanese colorectal adenocarcinomas

NTRK fusion-positive tumors are known to be highly sensitive to TRK inhibitors, such as larotrectinib and entrectinib. Therefore, identification of patients who can potentially benefit from these inhibitors is important; however, the frequency of NTRK fusions in Japanese patients with colorectal can...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashiro, Yuya, Kurihara, Taisei, Hayashi, Takuo, Suehara, Yoshiyuki, Yao, Takashi, Kato, Shunsuke, Saito, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952565/
https://www.ncbi.nlm.nih.gov/pubmed/33707574
http://dx.doi.org/10.1038/s41598-021-85075-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952565/
https://www.ncbi.nlm.nih.gov/pubmed/33707574
http://dx.doi.org/10.1038/s41598-021-85075-y

Ejemplares similares